Jennifer Furin

Recent Contributions

Reply to Expert Panel Feb. 20-24: Management of Second Line anti-TB Drugs: Getting it right

Feb. 24, 2012
Dear Colleagues: Thank you for participating in this panel, which brings together many of the leaders in TB and MDR-TB control. I would ask if members of the panel could please comment on the status of pediatric second-line antituberculous drugs. Currently, the only second-line agent available in a pediatric form ...

Recent Recommendations

None at this time.